Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study-Reference-Cited by-同舟云学术

Clinical effects of rifaximin in patientswith hepatic encephalopathy intolerant or nonresponsive to previous lactulose treatment: An open-label, pilot study

Published:2004-09 Issue:5 Volume:65 Page:413-422
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Sama Claudia,Morselli-Labate Antonio Maria,Pianta Paolo,Lambertini Laura,Berardi Sonia,Martini Gabriella

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference24 articles.

1. The mechanism of hepatic coma;Zieve;Hepatology,1981

2. Mechanisms of hepatic encephalopathy;Capocaccia;Gastroenterol Int,1989

3. Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: A double blind, randomized clinical trial;Uribe;Hepatology,1987

4. Adverse reactions and side effects of lactulose and related agents;Conn,1988

5. Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy;Tarao;Gut,1990

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis;Cochrane Database of Systematic Reviews;2023-07-19

2. Ziziphus spina-christi Leaf-Derived Carbon Dots as a Fluorescence Nanosensor to Evaluate Rifaximin Antibacterial via Inner Filter Effect: Greenness and Whiteness Studies;Chemosensors;2023-05-03

3. An anodically pretreated boron-doped diamond electrode surface for square-wave adsorptive stripping voltammetric quantification of the non-absorbable antibiotic rifaximin in the pharmaceutical formulation;Diamond and Related Materials;2023-02

4. Non-Lactulose Medication Therapies for the Management of Hepatic Encephalopathy: A Literature Review;Journal of Pharmacy Practice;2020-09-03

5. Effects of rifaximin versus nonabsorbable disaccharides in hepatic encephalopathy;GastroHep;2018-11-19